Validation of Breast Cancer Biomarkers Identified by Mass Spectrometry
Open Access
- 1 April 2006
- journal article
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 52 (4) , 771-772
- https://doi.org/10.1373/clinchem.2005.064972
Abstract
Li et al. (1) should be congratulated for a valiant effort to validate 3 previously identified serum breast cancer biomarkers by surface-enhanced laser desorptiThis publication has 11 references indexed in Scilit:
- Independent Validation of Candidate Breast Cancer Serum Biomarkers Identified by Mass SpectrometryClinical Chemistry, 2005
- Seldi-Tof Mass Spectrometry for Cancer Biomarker Discovery and Serum Proteomic DiagnosticsPharmacogenomics, 2005
- Influences of Blood Sample Processing on Low–Molecular-Weight Proteome Identified by Surface-Enhanced Laser Desorption/Ionization Mass SpectrometryClinical Chemistry, 2005
- Analytical and Preanalytical Biases in Serum Proteomic Pattern Analysis for Breast Cancer DiagnosisClinical Chemistry, 2005
- Diagnostic Proteomics: Back to Basics?Clinical Chemistry, 2005
- Signal in Noise: Evaluating Reported Reproducibility of Serum Proteomic Tests for Ovarian CancerJNCI Journal of the National Cancer Institute, 2005
- Bias as a threat to the validity of cancer molecular-marker researchNature Reviews Cancer, 2005
- Mass Spectrometry as a Diagnostic and a Cancer Biomarker Discovery ToolMolecular & Cellular Proteomics, 2004
- Analysis of Serum Proteomic Patterns for Early Cancer Diagnosis: Drawing Attention to Potential ProblemsJNCI Journal of the National Cancer Institute, 2004
- Proteomic Patterns in Biological Fluids: Do They Represent the Future of Cancer Diagnostics?Clinical Chemistry, 2003